522 related articles for article (PubMed ID: 20304038)
1. EV71: an emerging infectious disease vaccine target in the Far East?
Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
[TBL] [Abstract][Full Text] [Related]
2. [An overview of the evolution of EV71 vaccine].
Li M; Yin Y; Li J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):933-6. PubMed ID: 20842875
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus 71 vaccine: close but still far.
Zhang D; Lu J; Lu J
Int J Infect Dis; 2010 Sep; 14(9):e739-43. PubMed ID: 20400350
[TBL] [Abstract][Full Text] [Related]
4. Development of enterovirus 71 vaccines.
Lee MS; Chang LY
Expert Rev Vaccines; 2010 Feb; 9(2):149-56. PubMed ID: 20109026
[TBL] [Abstract][Full Text] [Related]
5. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
Liu CC; Chow YH; Chong P; Klein M
Vaccine; 2014 Oct; 32(47):6177-82. PubMed ID: 25218294
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community.
Sanders SA; Herrero LJ; McPhie K; Chow SS; Craig ME; Dwyer DE; Rawlinson W; McMinn PC
Arch Virol; 2006 May; 151(5):1003-13. PubMed ID: 16369861
[TBL] [Abstract][Full Text] [Related]
7. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
Klein MH
Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
[TBL] [Abstract][Full Text] [Related]
8. Review of enterovirus 71 vaccines.
Chong P; Liu CC; Chow YH; Chou AH; Klein M
Clin Infect Dis; 2015 Mar; 60(5):797-803. PubMed ID: 25352588
[TBL] [Abstract][Full Text] [Related]
9. Diseases caused by enterovirus 71 infection.
Lee TC; Guo HR; Su HJ; Yang YC; Chang HL; Chen KT
Pediatr Infect Dis J; 2009 Oct; 28(10):904-10. PubMed ID: 20118685
[TBL] [Abstract][Full Text] [Related]
10. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).
Mao QY; Wang Y; Bian L; Xu M; Liang Z
Expert Rev Vaccines; 2016 May; 15(5):599-606. PubMed ID: 26732723
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai.
Zeng M; El Khatib NF; Tu S; Ren P; Xu S; Zhu Q; Mo X; Pu D; Wang X; Altmeyer R
J Clin Virol; 2012 Apr; 53(4):285-9. PubMed ID: 22265829
[TBL] [Abstract][Full Text] [Related]
12. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011.
Ni H; Yi B; Yin J; Fang T; He T; Du Y; Wang J; Zhang H; Xie L; Ding Y; Gu W; Zhang S; Han Y; Dong H; Su T; Xu G; Cao G
J Clin Virol; 2012 Aug; 54(4):342-8. PubMed ID: 22652041
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018.
Han Y; Chen Z; Zheng K; Li X; Kong J; Duan X; Xiao X; Guo B; Luan R; Long L
Pediatr Infect Dis J; 2020 Oct; 39(10):969-978. PubMed ID: 32433221
[TBL] [Abstract][Full Text] [Related]
15. Expression and immunogenicity of novel subunit enterovirus 71 VP1 antigens.
Xu J; Wang S; Gan W; Zhang W; Ju L; Huang Z; Lu S
Biochem Biophys Res Commun; 2012 Apr; 420(4):755-61. PubMed ID: 22450314
[TBL] [Abstract][Full Text] [Related]
16. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.
Liang Z; Mao Q; Gao Q; Li X; Dong C; Yu X; Yao X; Li F; Yin W; Li Q; Shen X; Wang J
Vaccine; 2011 Dec; 29(52):9668-74. PubMed ID: 22015395
[TBL] [Abstract][Full Text] [Related]
17. Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
In HJ; Lim H; Lee JA; Lee SR; Jin YB; Jeong KJ; Hyeon JY; Yoo JS; Lee JW; Choi YK; Lee SW
PLoS One; 2018; 13(10):e0202552. PubMed ID: 30278051
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
19. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
20. Human enterovirus 71 and hand, foot and mouth disease.
Wong SS; Yip CC; Lau SK; Yuen KY
Epidemiol Infect; 2010 Aug; 138(8):1071-89. PubMed ID: 20056019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
